Andere Sprachen Dr. Reddy's Laboratories Limited

Aktien

945997

INE089A01023

500124

Markt geschlossen - Bombay S.E. Andere Börsenplätze 12:18:14 18.04.2024			% 5 Tage	% 1. Jan.
5’959 ^INR	-1.54%		-3.25%	+2.78%

18.04.	Das indische Unternehmen Biocon entwickelt seine eigene Version von Wegovy, klinische Studie wahrscheinlich nächstes Jahr	RE
18.04.	Asiatische Aktien, die in den USA als American Depositary Receipts gehandelt werden, tendieren im Donnerstagshandel niedriger	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

India's Biocon developing its own version of Wegovy, clinical trial likely next year	18.04.
Asian Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading	18.04.
Asian Equities Traded in the US as American Depositary Receipts Remain Flat in Wednesday Trading	17.04.
Financial, Telecoms Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Sharply Lower Tuesday	16.04.
Dr Reddy Laboratories : . Reddy's Investor Presentation - Sep 2023	12.04.
Dr. Reddy's Launches Migraine Management Device Nerivio in Germany	10.04.
Dr Reddy Laboratories : . Reddy’s launches ug-free migraine management device Nerivio® in Europe following successful launch in India - Form 6-K	10.04.
Dr. Reddy's Launches Migraine Management Wearable in Germany	10.04.
Dr Reddy Laboratories : Press Release Nerivio (Global) - Dr. Reddy's launches Nerivio in Europe	10.04.
Dr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatment	10.04.
Asian Equities Traded in the US as American Depositary Receipts Start Week on Strong Note in Monday Trading	08.04.
Sector Update: Health Care Stocks Rise Late Afternoon	05.04.
Dr. Reddy's Laboratories, Bayer Collaborate to Distribute Second Brand of Heart Failure Drug in India	05.04.
Asian Equities Traded in the US as American Depositary Receipts Nudge Higher in Friday Trading, End Week Lower	05.04.
Dr Reddy Laboratories : Bayer and Dr. Reddy’s sign a marketing and distribution agreement for second brand of Vericiguat™ in India - Form 6-K	05.04.
Bayer and Dr. Reddy's Sign A Marketing and Distribution Agreement for Second Brand of Vericiguat in India	05.04.
Dr Reddy Laboratories : Press Release_Bayer and Dr. Reddy’s sign a marketing and distribution agreement for second brand of Vericiguat™ in India	05.04.
Asian Equities Traded in the US as American Depositary Receipts Rebound in Early Wednesday Trading	03.04.
Indian Equities Close with Marginal Loss on Wednesday as Traders Scale Down Hopes on US Rate Cuts	03.04.
Asian Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading	01.04.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Dr. Reddy's Laboratories Limited

Aktien

945997

INE089A01023

500124

Andere Sprachen

Filter